Infrastructure portfolio remained flat in Q4 but achieved its strongest calendar year in three years, outperforming its benchmark. Rising interest rates impacted REITs and utilities, while natural gas pipelines benefited from data center and AI trends. Over 80% of portfolio holdings increased dividends annually over the past 5 years, surpassing the large-cap dividend-paying universe.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA), is scheduled to present virtually at the following healthcare conferences: March 4, 2025 at 1:50pm ET at TD Cowen's 45th Annual Healthcare Conference. March 11, 2025 at 1:30pm ET at Barclays' 27th Annual Global Healthcare Conference. March 19, 2025 at 2:15pm ET at KeyBanc's 5th Annual Healthcare Forum. March 20, 2025 at 10:00a...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from ...
Equity markets have been volatile over the past week as some of the industry leaders in artificial intelligence (AI) -- which make up a large percentage of indexes like the Nasdaq Composite -- have been encountering stiff competition out of China.
Trump has pledged to protect Social Security and Medicare throughout his campaign, one analyst noted, but this was the first time he added Medicaid to the list.
Cincinnati, Ohio, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Ensemble, the nation's leading revenue cycle managed services company for healthcare organizations, is pleased to announce that Bill Rutherford, former Executive Vice President and Chief Financial Officer of HCA Healthcare, has joined its Board of Managers.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that 49 of its hospitals were named on the 2025 Healthgrades America's 250 Best Hospitals list, which recognizes the top 5% of hospitals in the country for clinical excellence. Based exclusively on patient outcomes, the annual designation is reserved for hospital...
HCA released Q4 and Full-Year FY24 earnings on Friday, January 24th beating consensus for both EPS and Revenue. Along with a strong core business, industry tailwinds are accelerating, driving greater revenue potential and mitigating cost-growth. At a DCF-generated price target of $437, 41% upside from today's pricing, I raise my rating from buy to strong buy.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.